Skip to main content
. 2022 Oct 1;33(10):838–843. doi: 10.5152/tjg.2022.21726

Table 1.

Comparison of Anti-HCV (+) Patients According to Age Groups Before and During COVID-19

Total Anti-HCV(+) Patients 18-35 35-45 45-55 55-65 >65
Before COVID-19 674 74 (11%) 86 (12.7%) 101 (15) 177 (26.3%) 236 (35%)
During COVID-19 480 69 (14.4%) 68 (14.3%) 87 (18.1%) 126 (26.2%) 130 (27%)
P .084 .302 .154 .997 .004

HCV, hepatitis C virus.

P <.05 is the signifant cut off point.